Candel Therapeutics, Inc. CADL 深 沪
等待开盘 03-26 09:30:00 美东时间
5.07
+0.260
+5.41%
华盛通- 最 高5.13
- 今 开4.90
- 成交量 81.37万股
- 最 低 4.88
- 昨 收 4.81
- 总市值 3.71亿
- 52周最高 7.25
- 市盈率 静 --
- 换手率 1.11%
- 52周最低 4.25
- 委 比 -75.78%
- 总股本 7324.69万
- 历史最高 14.78
- 量 比 1.32
- 振 幅 5.20%
- 历史最低 0.66
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Non-Small Cell Lung Cancer Treatment
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with aglatimagene
03-17 20:12
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
Candel Therapeutics Q4 EPS $(0.54) Misses $(0.24) Estimate
Candel Therapeutics (NASDAQ:CADL) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.24) by 120.41 percent. This is a 35 percent decrease over losses of $(0.40) per share
03-12 20:25
Candel Therapeutics To Present New Data From Phase 3 Clinical Trial Of Aglatimagene Besadenovec In Patients With Intermediate- To High-Risk Localized Prostate Cancer At AUA 2026 Annual Meeting Plenary Program
Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that
03-09 20:17
Akamai Technologies, Inseego, Ardelyx And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around...
02-20 21:03
Why Is Candel Therapeutics Stock Falling Friday?
Candel Therapeutics stock down on public offering pricing, intends to use proceeds for cancer therapies and development costs.
02-20 18:55
Candel Therapeutics shares are trading lower after the company announced a $100 million public offering.
Candel Therapeutics shares are trading lower after the company announced a $100...
02-20 05:47
Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones gaining more than 600 points on Thur...
2025-12-12 01:18
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
